Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Weighted Average Incremental Borrowing Rate for Leases by Year
Weighted Average Incremental Borrowing Rate for Leases (%) (%)
Novartis Weighted Average Incremental Borrowing Rate for Leases: 4.1% in FY2025, up 0.1 pts from a year earlier.
Latest, FY2025
4.1%
Period ended Dec 31, 2025
Change on a year earlier
+0.1 pts
4.0% in FY2024
History
7 years
Since FY2019
Sources
5
Documents cited below
Where the FY2025 figure comes from
Source: Novartis Form 20-F (0001114448-26-000004) ↗
Reported in Form 20-F Note 10.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Weighted Average Incremental Borrowing Rate for Leases (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4.1% | +0.1 pts | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2024 | Dec 31, 2024 | 4.0% | +0.5 pts | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2023 | Dec 31, 2023 | 3.5% | +0.2 pts | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2022 | Dec 31, 2022 | 3.3% | +0.1 pts | Novartis Form 20-F (0001370368-25-000004) ↗ |
| FY2021 | Dec 31, 2021 | 3.2% | -0.2 pts | Novartis Form 20-F (0001370368-24-000004) ↗ |
| FY2020 | Dec 31, 2020 | 3.4% | -0.5 pts | Novartis Form 20-F/A (0001370368-23-000048) ↗ |
| FY2019 | Dec 31, 2019 | 3.9% | – | Novartis Form 20-F (0001370368-22-000010) ↗ |
Cite this data
StockData. (2026). Novartis Weighted Average Incremental Borrowing Rate for Leases (%), annual FY2019–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/ops-lease-rate-pct
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.